Read the First Edition of The Lens, a new magazine by LSI
Learn More About International Stem Cell (OTCQB: ISCO) (aka ISCO)
International Stem Cell (OTCQB: ISCO) (aka ISCO)
image
The world\'s first homozygous parthenogenetic stem cell lines that can provide therapeutic cells with the potential to be transplanted into hundreds of millions of individuals of differing ages and racial backgrounds with minimal risk of immune rejection
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
CEO presentation
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next